Brief: Pliant Therapeutics Inc Reports First Quarter Results

Pliant Therapeutics

09/05/2023 21:48

May 9 (Reuters) - Pliant Therapeutics Inc  PLRX.O :
    * PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
    * INTEGRIS-PSC 12-WEEK DATA EXPECTED IN Q3 OF 2023
    * BEACON-IPF PHASE 2B TRIAL INITIATION EXPECTED IN MID-2023
    * $577 MILLION IN CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS AT END OF Q1 2023, EXPECTED TO FUND OPERATIONS INTO
H2 OF 2026
    * QTRLY LOSS PER SHARE $0.67
    * Q1 EARNINGS PER SHARE VIEW $-0.67 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4jqDDF 
Further company coverage:  PLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))